Bristol-Myers Squibb Acquires Turning Point Therapeutics
Bristol-Myers Squibb acquired Turning Point Therapeutics for $4.1B. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Bristol-Myers Squibb
- Acquired Company
- Turning Point Therapeutics
- Price
- $4.1B
- Acquisition Type
- Acquisition
- Announced
- June 3, 2022
Canonical: https://fsome.com/acquisitions/bristol-myers-squibb-acquires-turning-point-therapeutics-8225911 · For the full deal terms, timeline, and press references, please enable JavaScript.